Table 1 Details of patients recruited for study
From: Aggrecan heterogeneity in articular cartilage from patients with osteoarthritis
Patient ID | Age | Gender | Condition†| Duration (yrs)a |
|---|---|---|---|---|
1 | 73 | F | OA | 12 |
2 | 69 | F | OA | 15 |
3 | 74 | M | OA | 2 |
4 | 71 | F | OA | 3 |
5 | 68 | F | OA | 4 |
6 | 61 | F | OA | 1 |
7 | 72 | F | OA | 3 |
8 | 75 | F | OA | 8 |
9 | 66 | F | OA | 1.5 |
10 | 59 | F | OA | 5 |
11 | 51 | M | Post-traumatic OA | 6 |
12 | 89 | M | OA | 4 |
13 | 78 | M | OA | 1 |
14 | 57 | F | AVN, secondary OA | 8 |
15 | 73 | F | OA | 3 |
16 | 59 | M | OA | 6 |
17 | 87 | F | OA | 1.5 |
18 | 89 | F | OA | 7 |
19 | 77 | M | OA | 1.5 |
20 | 77 | F | OA | 4 |
21 | 78 | M | OA | 5 |
22 | 71 | F | OA | 3 |
23 | 71 | M | OA | 1.5 |
24 | 46 | F | AVN, secondary OA | 4 |
25 | 50 | F | RA | 5.5 |
26 | 74 | M | OA | 1.5 |
27 | 69 | M | OA | 25 |
28 | 83 | F | OA | 3 |
29 | 89 | F | OA | 11 |
30 | 72 | F | OA second knee | 13 |
31 | 80 | F | OA | 20 |
32 | 77 | M | OA | 5 |
33 | 71 | F | OA | 11 |
34 | 95 | F | OA | 3 |